The risk of COVID-19 surface transmission is low, says the CDC, and is especially low outdoors.
COVID-19 is primarily a respiratory disease spread through the air and all the attention being paid to cleaning and disinfecting surfaces isn’t really necessary. Not only that but if done excessively, those activities actually do more harm than good, the Centers for Disease Control and Prevention (CDC) said yesterday.
The risk of surface transmission is low, said Vincent Hill, the CDC’s chief of the waterborne disease prevention branch. It’s a little more of a risk indoors, but outdoors it’s especially low because the sun and other factors can destroy the virus, Hill said.
The CDC went on to say COVID-19 does not last on porous surfaces, but can last longer on hard indoor surfaces, according to a report on CNN.
A study conducted last year by the CDC, National Institutes of Health (NIH), UCLA, and Princeton University investigated how long the virus remained infectious on different surfaces. The investigators found that SARS-CoV-2 is detectable in aerosols for up to 3 hours, on copper up to 4 hours, up to 24 hours on cardboard, and up to 3 days on plastic and stainless steel.
This was the widely-held view for some time as a virus spread through airborne transmission. Efforts to prevent it by masking, good indoor air circulation, and social distancing remain important efforts, and one new study shows the aforementioned first 2 may be of greater importance.
In a study done by the University of Central Florida, investigators’ findings suggest good ventilation and masks are significantly more important in reducing the airborne spread of COVID-19 than social distancing. The constant current of airflow caused by the ventilation system forces the air to circulate and be processed through an air filter, which removes a portion of the aerosols. The findings are in line with recent recommendations from the CDC.
As the US continues to ramp up its COVID-19 vaccine efforts, it is important to follow the latest CDC guidelines to protect against the virus.
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.